Interferon beta

Recombinant interferon beta, I million units three times weekly for 3 weeks has been compared with placebo in a trial of 35 patients.37

Table 26.5 Randomised controlled trials evaluating BEC-5 in the treatment of basal cell carcinoma

Study Method Participants Interventions Outcomes Notes

Table 26.5 Randomised controlled trials evaluating BEC-5 in the treatment of basal cell carcinoma

Study Method Participants Interventions Outcomes Notes

Punjabi et al,

Multicentre

94 patients

T1: BEC-5; T2:

Patients reviewed

10 patients in T1 did

20003B (UK)

Method of

BP BCCs

vehicle; twice daily

every 2 weeks

not complete the

randomisation

Age 32-95 years

under occlusion for

Repeat punch biopsy

study

not known

8 weeks

at 8 weeks on 84 patients

See Table 26.1 for abbreviations.

See Table 26.1 for abbreviations.

0 0

Post a comment